IGF1 and obstructive sleep apnea syndrome: Patients with OSAHS also exhibited higher IGF-1 levels (ng/mL) compared to those without OSAHS, with an average of 936.2 ± 447.2 ng/mL, showing a statistically significant difference (p = 0.006) between the groups (Figure 2).